BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29788358)

  • 1. Microbial Signatures as a Predictive Tool in IBD-Pearls and Pitfalls.
    Waldschmitt N; Metwaly A; Fischer S; Haller D
    Inflamm Bowel Dis; 2018 May; 24(6):1123-1132. PubMed ID: 29788358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia.
    Lim JS; Lim MY; Choi Y; Ko G
    Mol Brain; 2017 Apr; 10(1):14. PubMed ID: 28427452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Sundin J; Öhman L; Simrén M
    Psychosom Med; 2017 Oct; 79(8):857-867. PubMed ID: 28422780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.
    Kerman DH
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):707-17. PubMed ID: 27633598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
    Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
    Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Microbiome in Patients With Inflammatory Diseases.
    Somineni HK; Kugathasan S
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota and inflammatory bowel diseases.
    Miyoshi J; Chang EB
    Transl Res; 2017 Jan; 179():38-48. PubMed ID: 27371886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
    Ray A; Dittel BN
    Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
    Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
    Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research.
    Zhang S; Cao X; Huang H
    Front Cell Infect Microbiol; 2017; 7():51. PubMed ID: 28286741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks.
    Vázquez-Baeza Y; Hyde ER; Suchodolski JS; Knight R
    Nat Microbiol; 2016 Oct; 1():16177. PubMed ID: 27694806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Gonçalves P; Araújo JR; Di Santo JP
    Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.
    Dolan KT; Chang EB
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27346644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.